Acumen Pharmaceuticals
ABOS
ABOS
70 hedge funds and large institutions have $43.6M invested in Acumen Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
Holders
70
Holding in Top 10
–
Calls
$46K
Puts
$2K
Top Buyers
| 1 | +$945K | |
| 2 | +$893K | |
| 3 | +$291K | |
| 4 |
Jane Street
New York
|
+$191K |
| 5 |
Goldman Sachs
New York
|
+$161K |
Top Sellers
| 1 | -$2.37M | |
| 2 | -$1.43M | |
| 3 | -$540K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$481K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$287K |
